Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001091292 | SCV001247228 | pathogenic | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV001449717 | SCV001652973 | uncertain significance | not specified | 2020-06-11 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Pathogenic. The c.1920+2T>C variant in PDE6B has been reported in the homozygous state in 4 siblings with retinitis pigmentosa; however parental testing was either not performed or not reported (Neveling 2012 PMID:22334370). This variant has also been identified in 0.002% (2/113282) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant occurs within the canonical splice site (+/- 1,2). However, computational tools are conflicting in their predictions for a splicing impact. In summary, while there is suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied: PP1, PM2, PVS1_Moderate. |
Clinical Genetics, |
RCV001091292 | SCV001917901 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001091292 | SCV001954307 | pathogenic | not provided | no assertion criteria provided | clinical testing |